nSTRIDE

nSTRIDE injection is an autologous protein solution (APS) containing anti-inflammatory cytokines and anabolic growth factors. It is one of the latest biologic regenerative treatments used in treating knee osteoarthritis.

As an autologous solution, it is obtained by separating white blood cells and platelets from your blood and concentrating them in a small volume of plasma, using the APS kit.

The obtained APS is then injected directly into the osteoarthritic knee joint.

In osteoarthritis of the knee, inflammatory cytokines (bad proteins) are in higher concentrations than anti-inflammatory cytokines (good proteins). This imbalance leads to inflammation and gradual degeneration of the knee cartilage.

nSTRIDE APS contains concentrated anti-inflammatory cytokines, which inhibit the activity of inflammatory cytokines in the osteoarthritic knee. This reduces inflammation and slows down or halts the degeneration of the knee cartilage.

nSTRIDE is also rich in anabolic cytokines, which stimulate the synthesis of the cartilage matrix.

Reducing inflammation and stimulating repair of the damaged cartilage tissue helps slow down or reverse the progression of osteoarthritis.